Therapy for early COVID-19: a critical need

PS Kim, SW Read, AS Fauci - Jama, 2020 - jamanetwork.com
… in reducing time to recovery in adults hospitalized with COVID-19. These findings helped to
… been endorsed globally by multiple COVID-19 treatment guideline committees and have led …

Treatment algorithm for COVID-19: a multidisciplinary point of view

F Galluccio, T Ergonenc, A Garcia Martos… - Clinical …, 2020 - Springer
… Although children tend to experience only mild symptoms, previously healthy young adults
have also succumbed to COVID-19 [6, 7]. Although most patients have mild symptoms and …

Factors associated with US adults' likelihood of accepting COVID-19 vaccination

S Kreps, S Prasad, JS Brownstein, Y Hswen… - JAMA network …, 2020 - jamanetwork.com
… context of COVID-19 because of the unprecedented politicization of potential treatments and
… Trump’s promotion of an untested treatment, hydroxychloroquine, 33 and the administration’…

A review of potential treatments to date in COVID-19 patients according to the stage of the disease

T Alsuliman, L Alasadi, B Alkharat, M Srour… - Current Research in …, 2020 - Elsevier
… standard of care treatment in adults hospitalized adults with severe COVID-19 were recently
published [36]. The two arms of this study included 199 confirmed COVID-19 patients and …

Respiratory support for adult patients with COVID19

JS Whittle, I Pavlov, AD Sacchetti… - Journal of the …, 2020 - Wiley Online Library
Treatment of patients with COVID-19 who are hypoxic should follow the principles of treatment
of hypoxic patients resulting from other etiologies (Figure 2). For patients with O 2 sat <90…

[HTML][HTML] Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis

TC Lee, S Murthy, O Del Corpo, J Senécal… - Clinical Microbiology …, 2022 - Elsevier
… Nonetheless, as the median age of all groups was 56–58 years with interquartile ranges
ranged from 45–66, we believe that the data are overall representative of an adult population. …

[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature

Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
… and safety of intravenous remdesivir in adults admitted to hospital with severe COVID-19. …
literature on COVID-19 treatments. There is not yet a completely effective cure for COVID-19. …

Therapeutics for COVID-19

SS Toussi, JL Hammond, BS Gerstenberger… - Nature …, 2023 - nature.com
… Molnupiravir achieved an Emergency Use Authorization (EUA) in the United States on 23
December 2021 for the treatment of mild-to-moderate COVID-19 in adults at high risk for …

Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID-19 patients: a prospective, multicenter, open-label, randomized controlled …

C Chen, Y Zhang, J Huang, P Yin, Z Cheng… - Frontiers in …, 2021 - frontiersin.org
… and safety of favipiravir versus Arbidol as a treatment for COVID-19, we conducted a
prospective, randomized, controlled, open-label multicenter trial in adult patients with COVID-19. …

Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
… the new coronavirus or coronavirus disease 2019 (COVID-19)… as Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-… The ongoing COVID-19 pandemic with significant mortality, …